课题基金 / 基金详情

CLINICAL TRIAL: A MULTICENTER, DOUBLE-BLIND, PARALLEL GROUP, PLACEBO CONTROLLED

CLINICAL TRIAL: A MULTICENTER, DOUBLE-BLIND, PARALLEL GROUP, PLACEBO CONTROLLED
临床试验：多中心、双盲、平行组、安慰剂对照
批准号：
7719285
负责人：
ANDREW FEIGIN
金额：
$3.68万
依托单位：
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
依托单位国家：
美国
项目类别：
财政年份：
2008
资助国家：
美国
项目状态：
已结题
起止时间：
2008-04-22 至 2009-03-31
来源：
https://reporter.nih.gov/project-details/7719285
关键词：
Clinical TrialsComputer Retrieval of Information on Scientific Projects DatabaseCreatineDouble-Blind MethodFundingGaitGrantImpaired cognitionInstitutionMeasuresMedicalOutcomePlacebo ControlPlacebosResearchResearch PersonnelResourcesSourceUnited States National Institutes of Health

项目摘要

项目成果

ANDREW FEIGIN的其他基金

相关文献

中文摘要
翻译
该子项目是利用 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得主要资金， 因此可以在其他CRISP条目中表示。列出的机构是 中心，不一定是研究者的机构。 这项为期5年的研究将比较肌酸组与安慰剂组在多巴胺能治疗和最佳医疗实践背景下的主要结局，如通过PD功能、步行步态、认知障碍和整体功能测量。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This five year study will compare the primary outcome as measured by the PD functioning, ambulatory gait, cognitive impairment and global functioning in the creatine group versus the placebo group against a background of dopaminergic therapy and best medical practice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Brain Network Imaging: A Novel Biomarker for Preclinical Huntington's Disease
Brain Network Imaging: A Novel Biomarker for Preclinical Huntington's Disease
Brain Network Imaging: A Novel Biomarker for Preclinical Huntington's Disease
CLINICAL TRIAL: A STUDY OF CREATINE IN SUBJECTS WITH TREATED PARKINSON'S DISEASE